Comment from Parent Project Muscular Dystrophy

Summary: Parent Project Muscular Dystrophy (PPMD), a nonprofit organization for Duchenne muscular dystrophy, supports the FDA's draft guidance on the Plausible Mechanism Framework for individualized therapies. They advocate for regulatory flexibility, the use of natural history data and biomarkers, and the recognition of patient risk tolerance to accelerate access to treatments for rare genetic conditions.